Skip to content

The effect of sulfate magnesium on atrial fibrillation after open heart surgery

Investigating the effect of sulfate magnesium tablet on atrial fibrillation after coronary artery bypass grafting in Heshmat Hospital in 2019

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190413043252N1
Enrollment
70
Registered
2019-05-18
Start date
2019-05-22
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation and fluttery. IX 100-199 Diseases of the circulatory system

Interventions

Intervention 1: Intervention group: All pre-operative patients will be interviewed and the method will be explained to them and written informed consent will be obtained. In both groups, a blood sampl

Sponsors

Rasht University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Only cardiopulmonary bypass graft surgery (not associated with valve operation). First-time open heart surgery Ejection Fraction(EF) more than 35%

Exclusion criteria

Exclusion criteria: History of Previous arterial fibrillation(AF) History of kidney disease History of taking magnesium and showing an allergic reaction History of taking antiarrhythmic drugs (such as amiodarone -digoxin -warfarin) Being pregnant Having a pacemaker AV BLOCK In the ECG

Design outcomes

Primary

MeasureTime frame
Effect on prevention of AF rhythm in patients with coronary artery bypass graft surgery. Timepoint: 24-hour patient monitoring until the fifth day. Method of measurement: ECG monitoring.

Secondary

MeasureTime frame
Reducing hospitalization time in the ICU and hospital, and thus reducing patient hospitalization costs. Timepoint: After patient's discharge from hospital. Method of measurement: Number of hospitalization days.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGholamreza Kanani

Rasht University of Medical Sciences

dr_kanani@gums.ac.ir+98 13 3366 9066

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026